BDBM667621 N-(3,6-dimethyl-1,2,3,4- tetrahydronaphthalen-1-yl)- 2-oxo-6-(trifluoromethyl)- 1,2-dihydropyridine-3- carboxamide::US11957687, Compound 391

SMILES CC1CC(NC(=O)c2ccc([nH]c2=O)C(F)(F)F)c2ccc(C)cc2C1

InChI Key InChIKey=ONKWKEYVSQRPHW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667621   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM667621(US11957687, Compound 391 | N-(3,6-dimethyl-1,2,3,4...)
Affinity DataIC50: 50nMAssay Description:Compounds of the disclosure were screened for their ability to block HSD17B13 function using an enzymatic blocking assay. HSD17B13 activity was quant...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent